Given the vital role of cytokine storm in the pathogenesis of COVID-19, agents able to reduce the release of many cytokines involved in the initiation and progression of inflammation (such as IFN-γ, IL-6, and TNF-α) may assist in preventing the progression of the disease. The gene discussed is IFNG; the disease is COVID-19.